Walleye Trading’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.4M Sell
175,300
-16,800
-9% -$2.35M 0.04% 439
2025
Q4
$23.6M Sell
192,100
-18,700
-9% -$2.27M 0.03% 550
2025
Q3
$23.4M Sell
210,800
-190,800
-48% -$21.7M 0.04% 527
2025
Q2
$44.5M Buy
401,600
+174,900
+77% +$18.6M 0.08% 259
2025
Q1
$25.4M Buy
226,700
+85,200
+60% +$8.79M 0.06% 365
2024
Q4
$13.1M Sell
141,500
-10,300
-7% -$927K 0.03% 653
2024
Q3
$12.7M Buy
151,800
+26,500
+21% +$2.02M 0.03% 651
2024
Q2
$8.6M Buy
125,300
+8,500
+7% +$567K 0.02% 758
2024
Q1
$8.56M Sell
116,800
-100,800
-46% -$7.75M 0.02% 810
2023
Q4
$17.6M Sell
217,600
-37,600
-15% -$2.93M 0.04% 508
2023
Q3
$19.1M Sell
255,200
-90,300
-26% -$6.95M 0.05% 386
2023
Q2
$26.6M Buy
345,500
+99,400
+40% +$7.93M 0.08% 219
2023
Q1
$20.4M Buy
246,100
+98,000
+66% +$8.12M 0.04% 378
2022
Q4
$12.7M Sell
148,100
-270,300
-65% -$21.4M 0.04% 533
2022
Q3
$25.8M Buy
418,400
+164,600
+65% +$10.4M 0.08% 241
2022
Q2
$15.7M Buy
253,800
+36,800
+17% +$2.28M 0.05% 416
2022
Q1
$12.9M Buy
217,000
+117,400
+118% +$7.5M 0.04% 519
2021
Q4
$7.23M Buy
99,600
+20,400
+26% +$1.41M 0.02% 770
2021
Q3
$5.53M Buy
79,200
+32,000
+68% +$2.25M 0.02% 867
2021
Q2
$3.25M Sell
47,200
-18,500
-28% -$1.24M 0.01% 1104
2021
Q1
$4.25M Buy
65,700
+32,600
+98% +$2.1M 0.02% 766
2020
Q4
$1.93M Sell
33,100
-41,700
-56% -$2.52M 0.01% 1408
2020
Q3
$4.73M Sell
74,800
-41,600
-36% -$2.88M 0.03% 601
2020
Q2
$8.96M Buy
116,400
+500
+0.4% +$38.3K 0.06% 309
2020
Q1
$8.66M Buy
115,900
+94,000
+429% +$6.5M 0.07% 223
2019
Q4
$1.42M Sell
21,900
-59,700
-73% -$3.89M 0.01% 1495
2019
Q3
$5.17M Buy
81,600
+39,700
+95% +$2.6M 0.04% 454
2019
Q2
$2.83M Sell
41,900
-235,700
-85% -$15.5M 0.02% 795
2019
Q1
$18M Buy
277,600
+223,200
+410% +$14.8M 0.14% 108
2018
Q4
$3.4M Sell
54,400
-8,100
-13% -$566K 0.03% 695
2018
Q3
$4.83M Buy
62,500
+34,500
+123% +$2.61M 0.03% 671
2018
Q2
$1.98M Sell
28,000
-500
-2% -$35.3K 0.01% 1363
2018
Q1
$2.15M Sell
28,500
-76,000
-73% -$6.04M 0.01% 1146
2017
Q4
$7.49K Sell
104,500
-23,600
-18% -$1.79M 0.04% 461
2017
Q3
$10.4K Sell
128,100
-9,200
-7% -$703K 0.05% 302
2017
Q2
$9.71K Sell
137,300
-79,900
-37% -$5.32M 0.06% 310
2017
Q1
$14.8K Buy
217,200
+150,300
+225% +$10.6M 0.1% 136
2016
Q4
$4.79M Sell
66,900
-2,600
-4% -$193K 0.03% 469
2016
Q3
$5.5M Buy
69,500
+16,100
+30% +$1.31M 0.04% 392
2016
Q2
$4.45M Sell
53,400
-209,400
-80% -$18.6M 0.03% 496
2016
Q1
$24.1M Buy
262,800
+27,400
+12% +$2.47M 0.21% 64
2015
Q4
$23.8M Buy
235,400
+137,500
+140% +$14.3M 0.23% 68
2015
Q3
$9.62M Sell
97,900
-35,500
-27% -$3.94M 0.09% 165
2015
Q2
$15.6M Sell
133,400
-89,600
-40% -$9.79M 0.15% 94
2015
Q1
$21.9M Buy
223,000
+222,800
+111,400% +$22.6M 0.22% 54
2014
Q4
$18K Sell
200
-6,400
-97% -$662K ﹤0.01% 3722
2014
Q3
$703K Sell
6,600
-7,200
-52% -$705K 0.01% 1049
2014
Q2
$1.14K Buy
13,800
+13,300
+2,660% +$1.04M 0.02% 728
2014
Q1
$35 Sell
500
-88,100
-99% -$6.91M ﹤0.01% 2874
2013
Q4
$6.66M Buy
88,600
+1,100
+1% +$76.6K 0.06% 213
2013
Q3
$5.5M Buy
87,500
+5,100
+6% +$305K 0.06% 251
2013
Q2
$4.22M Buy
+82,400
New +$4.29M 0.04% 345

Other funds holding GILD

Walleye Trading's GILD Position: Q2 2025 in Review

Walleye Trading sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 25,289 shares — an estimated $2.69M sold.

Walleye Trading first reported a position in GILD in Q4 2013 and held it in 36 quarters. The position peaked at $12.8M in Q1 2018. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Walleye Trading reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 25,289 Gilead Sciences shares in Q2 2025, an estimated $2.69M.
  • Walleye Trading first reported a position in Gilead Sciences in Q4 2013 and held it in 36 quarters.
  • Walleye Trading's Gilead Sciences position peaked at $12.8M in Q1 2018.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.